116 related articles for article (PubMed ID: 7535245)
21. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
[TBL] [Abstract][Full Text] [Related]
22. Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: comparison between recombinant human granulocyte colony-stimulating factor (CSF) and granulocyte-monocyte CSF.
Nagler A; Binet C; Mackichan ML; Negrin R; Bangs C; Donlon T; Greenberg P
Blood; 1990 Oct; 76(7):1299-307. PubMed ID: 1698477
[TBL] [Abstract][Full Text] [Related]
23. Effects of recombinant growth factors on radiation survival of human bone marrow progenitor cells.
Uckun FM; Gillis S; Souza L; Song CW
Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):415-35. PubMed ID: 2466026
[TBL] [Abstract][Full Text] [Related]
24. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
25. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
26. Purified unfractionated G-CSF/chemotherapy mobilized CD34+ peripheral blood progenitors and not bone marrow CD34+ progenitors undergo selective erythroid differentiation in liquid culture in the presence of erythropoietin and stem cell factor.
Pierelli L; Scambia G; Menichella G; Fattorossi A; Ciarli M; Bonanno G; Battaglia A; d'Onofrio G; Benedetti Panici P; Iacone A; Mancuso S; Leone G
Br J Haematol; 1997 Jan; 96(1):55-63. PubMed ID: 9012687
[TBL] [Abstract][Full Text] [Related]
27. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
Merchav S; Wagemaker G; Souza LM; Tatarsky I
Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245
[TBL] [Abstract][Full Text] [Related]
28. Initiation in DNA synthesis by colony-stimulating factors in subsets of human CD34+ marrow cells.
Strauss LC; Welsh SB; Civin CI
Exp Hematol; 1991 Sep; 19(8):734-41. PubMed ID: 1714400
[TBL] [Abstract][Full Text] [Related]
29. Combined measurement of growth and differentiation in suspension cultures of purified human CD34-positive cells enables a detailed analysis of myelopoiesis.
Kerst JM; Slaper-Cortenbach IC; von dem Borne AE; van der Schoot CE; van Oers RH
Exp Hematol; 1992 Nov; 20(10):1188-93. PubMed ID: 1385196
[TBL] [Abstract][Full Text] [Related]
30. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
31. Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3, and recombinant murine granulocyte/macrophage colony-stimulating factor.
Broxmeyer HE; Williams DE; Hangoc G; Cooper S; Gillis S; Shadduck RK; Bicknell DC
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3871-5. PubMed ID: 3495800
[TBL] [Abstract][Full Text] [Related]
32. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation.
Ferrajoli A; Talpaz M; Kurzrock R; Harris D; Van Q; Estey EH; Estrov Z
Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
[TBL] [Abstract][Full Text] [Related]
34. Influence of combinations of cytokines on proliferation of isolated single cell-sorted human bone marrow hematopoietic progenitor cells in the absence and presence of serum.
Xiao M; Leemhuis T; Broxmeyer HE; Lu L
Exp Hematol; 1992 Feb; 20(2):276-9. PubMed ID: 1371967
[TBL] [Abstract][Full Text] [Related]
35. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
Grant S; Pettit GR; McCrady C
Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
[TBL] [Abstract][Full Text] [Related]
36. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
[TBL] [Abstract][Full Text] [Related]
37. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
Reid CD; Stackpoole A; Meager A; Tikerpae J
J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
[TBL] [Abstract][Full Text] [Related]
38. Transitional changes in immunophenotypic subpopulations of human peripheral blood CD34+ cells expanded in vitro.
Koizumi K; Sawada K; Sato N; Hirayama S; Yasukouchi T; Yamaguchi M; Takahashi TA; Sekiguchi S; Koike T
Exp Hematol; 1994 Nov; 22(12):1171-8. PubMed ID: 7523169
[TBL] [Abstract][Full Text] [Related]
39. In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplastic syndromes.
Thomas X; Guyotat D; Campos L; Shi ZH; Vila L; Ehrsam A; Fiere D
Leuk Res; 1991; 15(1):29-36. PubMed ID: 1705306
[TBL] [Abstract][Full Text] [Related]
40. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
